Timothy Matula Email & Phone Number

Allentown, Pa, Us

Allentown, Pennsylvania

Allentown, Pa, United States

Philadelphia, Pa

Greater Philadelphia Area

Responsible for sales of the Olympus Energy portfolio including: Thunderbeat (advanced bipolar and ultrasonic energy), Gyrus PK instruments, and generators (Thunderbeat and Gyrus G400) to surgeons into the operating room.

Eastern/Central Pa

Direct sale of Olympus Urology instruments for diagnostic and therapeutic procedures within hospital operating rooms, ambulatory centers and specialty offices.

Eastern/Central Pa

Direct sales of Olympus capital and disposable Surgical Energy devices

Responsible for sales objectives of products within multiple specialty markets - Gastroenterology, Cardiology, Rheumatology - as well as the primary care market. Collaborated with 5 area speakers to manage educational programs with Primary Care physicians. Selected as Regional Business Lead to implement and train field reps regarding new company initiatives.Cresset Winner (Top Sales Award 2011-2012)Launched 2 new anti-hypertensive agents generating 53TRx - #2 Regional RankRegional Business Lead (2012): Conducted training on all new data reporting applications, Company database navigation, Takeda Selling Model, Territory Management, and New Hire field trainingLaunched Colcrys to Specialists & Primary Care (Branded Colchicine Jun 2012) - #1 District Rank through first 2 months

Responsible for quarterly and annual sales objectives for the Endocrinologist market spanning the Eastern Pennsylvania. Coordinated with 4 separate Primary Care Teams increasing sales within the marketplace. Collaborated closely with 6 Endocrinologist speakers to manage multiple discussions with local Primary Care Physicians. Led all PCP Teams in developing cross-functional business plans, implementing brand initiatives, and team meetings.Took underperforming territory from 100 to 48th of 118 in first 3 quarters of 2010 Achieved Lantus Solostar (insulin delivery device) share growth of +5.61% (Q1 to Q3) in new territoryGenerated 27 consistent Apidra prescribers within new territoryPromoted Cardiovascular drug Plavix to area Cardiologists (June-Dec 2009)Index Portfolio Attainment (Lantus & Apidra) 2009: Ranked 1/43 within Philadelphia Region2008: 100.6% (Ranked 17/35 within Philadelphia Region) 2007: 105.25% (Ranked 7/19 within Philadelphia Region)2007 Apidra attainment: 107.6% - Launched Apidra (insulin glulisine) mid 2006 - 3rd to market rapid acting insulinRegional Diabetes Certified Field TrainerDiabetes Phase II Group Leader (4 separate Occasions - Diabetes portfolio training) Lead Facilitator – 2008 Diabetes Cross-TrainingPhiladelphia Regional Advisory Council Member